Article Cited by others

INVITED REVIEW

Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms

Huang Yu-Hua, Zhang Ya-Qun, Huang Jiao-Ti

Year : 2019| Volume: 21| Issue : 3 | Page no: 291-295

   This article has been cited by
 
1 The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC
Cheng-Fan Lee, Yu-An Chen, Elizabeth Hernandez, Rey-Chen Pong, Shihong Ma, Mia Hofstad, Payal Kapur, Haiyen Zhau, Leland WK Chung, Chih-Ho Lai, Ho Lin, Ming-Shyue Lee, Ganesh V Raj, Jer-Tsong Hsieh
Clinical and Translational Medicine. 2022; 12(2)
[Pubmed]  [Google Scholar] [DOI]
2 Molecular Mechanisms Underlying the Development of Neuroendocrine Prostate Cancer
Shiqin Liu, Busola Ruth Alabi, Qingqing Yin, Tanya Stoyanova
Seminars in Cancer Biology. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
Lina Merkens, Verena Sailer, Davor Lessel, Ella Janzen, Sarah Greimeier, Jutta Kirfel, Sven Perner, Klaus Pantel, Stefan Werner, Gunhild von Amsberg
Journal of Experimental & Clinical Cancer Research. 2022; 41(1)
[Pubmed]  [Google Scholar] [DOI]
4 Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective
Jian Huang, Biyun Lin, Benyi Li
Frontiers in Oncology. 2022; 12
[Pubmed]  [Google Scholar] [DOI]
5 CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers
Aaron R. Waddell,Haojie Huang,Daiqing Liao
Cancers. 2021; 13(12): 2872
[Pubmed]  [Google Scholar] [DOI]
6 Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation
Shian-Ren Lin,Hsiu-Lien Yeh,Yen-Nien Liu
Cancers. 2021; 13(14): 3452
[Pubmed]  [Google Scholar] [DOI]
7 Imaging of Neuroendocrine Prostatic Carcinoma
Ahmed Taher, Corey T. Jensen, Sireesha Yedururi, Devaki Shilpa Surasi, Silvana C. Faria, Tharakeshwar K. Bathala, Bilal Mujtaba, Priya Bhosale, Nicolaus Wagner-Bartak, Ajaykumar C. Morani
Cancers. 2021; 13(22): 5765
[Pubmed]  [Google Scholar] [DOI]
8 Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer
Thanakorn Pungsrinont, Julia Kallenbach, Aria Baniahmad
International Journal of Molecular Sciences. 2021; 22(20): 11088
[Pubmed]  [Google Scholar] [DOI]
9 The Role of the CREB Protein Family Members and the Related Transcription Factors in Radioresistance Mechanisms
Gianmarco Stati, Francesca Passaretta, Florelle Gindraux, Lucia Centurione, Roberta Di Pietro
Life. 2021; 11(12): 1437
[Pubmed]  [Google Scholar] [DOI]
10 Caryophyllene Oxide, the Active Compound Isolated from Leaves of Hymenaea courbaril L. (Fabaceae) with Antiproliferative and Apoptotic Effects on PC-3 Androgen-Independent Prostate Cancer Cell Line
Claudia Delgado,Gina Mendez-Callejas,Crispin Celis
Molecules. 2021; 26(20): 6142
[Pubmed]  [Google Scholar] [DOI]
11 Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs
Eva Slabáková, Zuzana Kahounová, Jirina Procházková, Karel Soucek
Non-Coding RNA. 2021; 7(4): 75
[Pubmed]  [Google Scholar] [DOI]
12 Epigenetic mechanisms underlying prostate cancer radioresistance
Catarina Macedo-Silva,Rosaria Benedetti,Fortunato Ciardiello,Salvatore Cappabianca,Carmen Jerónimo,Lucia Altucci
Clinical Epigenetics. 2021; 13(1)
[Pubmed]  [Google Scholar] [DOI]
13 Neuroendocrine cells of the prostate: Histology, biological functions, and molecular mechanisms
William Butler,Jiaoti Huang
Precision Clinical Medicine. 2021;
[Pubmed]  [Google Scholar] [DOI]
14 Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13
Kosuke Okasho,Kei Mizuno,Tomohiro Fukui,Yen-Yi Lin,Yuki Kamiyama,Takuro Sunada,Xin Li,Hiroko Kimura,Takayuki Sumiyoshi,Takayuki Goto,Takashi Kobayashi,Dong Lin,Yuzhuo Wang,Colin C. Collins,Takahiro Inoue,Osamu Ogawa,Shusuke Akamatsu
Cancer Science. 2021;
[Pubmed]  [Google Scholar] [DOI]
15 Molecular events in neuroendocrine prostate cancer development
Yong Wang,Yu Wang,Xinpei Ci,Stephen Y. C. Choi,Francesco Crea,Dong Lin,Yuzhuo Wang
Nature Reviews Urology. 2021;
[Pubmed]  [Google Scholar] [DOI]
16 Cancer cell’s neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction
Liyuan Yin,Peizhen Hu,Xianping Shi,Weiping Qian,Haiyen E. Zhau,Stephen J. Pandol,Michael S. Lewis,Leland W. K. Chung,Ruoxiang Wang
Scientific Reports. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]
17 Cellular growth factors as prospective therapeutic targets for combination therapy in androgen independent prostate cancer (AIPC)
Bhavana Jonnalagadda,Sumathy Arockiasamy,Sriram Krishnamoorthy
Life Sciences. 2020; : 118208
[Pubmed]  [Google Scholar] [DOI]
18 Androgen Deprivation Induces Reprogramming of Prostate Cancer Cells to Stem-Like Cells
Belén G. Sánchez,Alicia Bort,Diana Vara-Ciruelos,Inés Díaz-Laviada
Cells. 2020; 9(6): 1441
[Pubmed]  [Google Scholar] [DOI]
19 Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review
Jing Hu,Bo Han,Jiaoti Huang
Archives of Pathology & Laboratory Medicine. 2020; 144(3): 320
[Pubmed]  [Google Scholar] [DOI]
20 Prostate cancer: molecular and cellular mechanisms and their implications in therapy resistance and disease progression
Ninghan Feng,Jiaoti Huang
Asian Journal of Andrology. 2019; 0(0): 0
[Pubmed]  [Google Scholar] [DOI]
21 Incidental finding of a small cell neuroendocrine carcinoma of the ureter
Obinna Obi-Njoku,Chris Bell,Prashant Ravindran Menon,Iqbal Shergill
BMJ Case Reports. 2019; 12(7): e229290
[Pubmed]  [Google Scholar] [DOI]

 

Read this article